A newly published study in Clinical Cancer Research has implied the potential development of a completely new and much more accurate way to be able to identify risk for metastatic prostate cancer. The basic premise behind the new paper by Xu et al. (see also this news item on the ScienceDaily web site) is that […]![]()
